4.2 Article

Effects of royal jelly on liver paraoxonase activity in rats treated with cisplatin

Journal

TURKISH JOURNAL OF MEDICAL SCIENCES
Volume 42, Issue 3, Pages 367-375

Publisher

Tubitak Scientific & Technological Research Council Turkey
DOI: 10.3906/sag-1102-1373

Keywords

Arylesterase; cisplatin; oxidative stress; paraoxonase; royal jelly

Ask authors/readers for more resources

Aim: To evaluate the protective effects of royal jelly (RJ) on the changes caused by cisplatin in paraoxonase-1 (PON-1) and arylesterase (ARE) activities. Materials and methods: Twenty-four Sprague-Dawley rats were divided into 4 groups of 6: control, royal jelly (300 mg kg(-1) day(-1)), cisplatin (7 mg kg(-1) body weight), and royal jelly (300 mg kg(-1) day(-1)) plus a single dose of cisplatin (7 mg kg(-1) body weight). After the experimental procedures, blood and liver tissue samples were taken from each animal. The effects of RJ and cisplatin were evaluated by PON-1, ARE (in liver homogenates), and serum alanine aminotransferase measurements. The liver tissue was also histologically examined. Results: Administration of cisplatin reduced the PON-1 and ARE activities in the liver. However, in the rats given a pretreatment with RJ before the injection of cisplatin, the reduction caused by the cisplatin in the PON-1 and ARE activities was prevented at a significant level. These biochemical observations were supported by histological findings and suggested that RJ restored the cisplatin-induced structural alterations in the liver tissue by the way of its antioxidant, radical scavenging, and antiapoptotic effects. Conclusion: RJ may be a potential preventive agent against the hepatic toxicity associated with cisplatin therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available